|
Volumn 4, Issue 3, 2001, Pages 53-64
|
Comparative aspects of triptans in treating migraine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALMOTRIPTAN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CIMETIDINE;
DIHYDROERGOTAMINE;
ELETRIPTAN;
FROVATRIPTAN;
MAXALT MLT;
NARATRIPTAN;
NOSE SPRAY;
PLACEBO;
PROPRANOLOL;
RIZATRIPTAN;
SEROTONIN 1B AGONIST;
SEROTONIN 1D AGONIST;
SUMATRIPTAN SUCCINATE;
ZOLMITRIPTAN;
CARBAZOLE DERIVATIVE;
INDOLE DERIVATIVE;
OXAZOLIDINONE DERIVATIVE;
PIPERIDINE DERIVATIVE;
PYRROLIDINE DERIVATIVE;
SEROTONIN AGONIST;
SUMATRIPTAN;
TRIAZOLE DERIVATIVE;
TRYPTAMINE DERIVATIVE;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG PREFERENCE;
DRUG TOLERABILITY;
FATIGUE;
FLUSHING;
HEADACHE;
HEAT SENSATION;
HUMAN;
MALAISE;
MIGRAINE;
NAUSEA;
PARESTHESIA;
SENSORY DYSFUNCTION;
SIDE EFFECT;
SOMNOLENCE;
THORAX DISEASE;
UNITED STATES;
VERTIGO;
XEROSTOMIA;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
PATIENT SATISFACTION;
REVIEW;
TREATMENT OUTCOME;
CARBAZOLES;
CARDIOVASCULAR DISEASES;
HUMANS;
INDOLES;
MIGRAINE DISORDERS;
OXAZOLIDINONES;
PATIENT SATISFACTION;
PIPERIDINES;
PYRROLIDINES;
SEROTONIN AGONISTS;
SUMATRIPTAN;
TREATMENT OUTCOME;
TRIAZOLES;
TRYPTAMINES;
|
EID: 0035671774
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(01)90039-0 Document Type: Article |
Times cited : (14)
|
References (30)
|